Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice

Synapse

Volumn 60, Issue 7, 2006, Pages 479-484

  Nakamura, Shigeo ^a   Ago, Yukio ^a   Hayashi, Aiko ^a   Itoh, Soichi ^a   Kakuda, Michiya ^b   Hashimoto, Hitoshi ^a,b   Baba, Akemichi ^a   Matsuda, Toshio ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cocaine; Locomotor activity; Mouse; Osemozotan; Serotonin (5 HT) 1A receptor; WAY100635

Indexed keywords

BUPRENORPHINE; COCAINE; DOPAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OSEMOZOTAN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; MOUSE STRAIN; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR FLUID; MALE; MICE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; TIME FACTORS; UP-REGULATION;

EID: 33749581445     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20323     Document Type: Article

References (36)

1. Abe M, Tabata R, Saito K, Matsuda T, Baba A, Egawa M. 1996. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1, 3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. J Pharmacol Exp Ther 278:898-905.
2. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J Neurochem 83:353-359.
3. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45:1050-1056.
4. Ago Y, Nakamura S, Baba A, Matsuda T. 2005. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30:43-51.
5. 1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. Eur J Pharmacol 508:123-130.
6. 1A syndrome. Pharmacol Biochem Behav 57:897-908.
7. 1A antagonist WAY 100635 can block the low dose locomotor stimulant effects of cocaine. Brain Res 862:242-246.
8. 1A receptor site in the mediation of cocaine stimulant effects. Behav Brain Res 126:127-133.
9. 1A agonist/antagonist modification of cocaine stimulant effects: Implications for cocaine mechanisms. Behav Brain Res 132:37-46.
10. 1A receptor and behavioral stimulation in the rat: Effects of 8-OH-DPAT on spontaneous and cocaine-induced behavior. Psychopharmacology 177:46-54.
11. 1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res 1034:162-171.
12. 1A agonist 8-hydroxy-2(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: A microanalysis of locomotor activity. J Pharmacol Exp Ther 292:610-617.
13. Dulawa SC, Geyer MA. 2000. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170-2179.
14. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
15. Herges S, Taylor DA. 1998. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol Biochem Behav 59:595-611.
16. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 338:463-471.
17. 1A receptors. Jpn J Pharmacol 69:357-366.
18. 1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45:67-77.
19. 1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res 134:337-346.
20. 1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: An in vivo microdialysis study. Neuropharmacology 44:592-603.
21. Nakamura S, Ago Y, Itoh S, Koyama Y, Baba A, Matsuda T. 2005. Effect of zotepine on dopamine, serotonin and noradrenaline release in the prefrontal cortex. Eur J Pharmacol 528:95-98.
22. O'Neill MF, Heron-Maxwell CL, Shaw G. 1999. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacol Biochem Behav 63:237-243.
23. Prasad BM, Hochstatter T, Sorg BA. 1998. Expression of cocaine sensitization: Regulation by the medial prefrontal cortex. Neuroscience 88:765-774.
24. 1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav Pharmacol 8:699-706.
25. Rigdon GC, Weatherspoon JK. 1992. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486-493.
26. Ritz MC, Cone EJ, Kuhar MJ. 1990. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity study. Life Sci 46:635-645.
27. Rocha BA, Scearch-Levie K, Lucas JJ, Hiroi N, Castanon N, Crabbe JC, Nestler EJ, Hen R. 1998. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393:175-178.
28. Roughan JV, Flecknell PA. 2002. Buprenorphine: A reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab Anim 36:322-343.
29. 1A receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br J Pharmacol 129:1028-1034.
30. 1A receptor activation in isolated mice. Eur J Pharmacol 432:163-166.
31. 1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze. Eur J Pharmacol 458:141-144.
32. 1A receptor agonist MKC-242 reverses isolation rearing-induced deficit of prepulse inhibition in mice. Psychopharmacology 170:73-79.
33. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283-290.
34. Sipes TA, Geyer MA. 1995. 8-OH-DPAT disruption of prepulse inhibition in rats: Reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117:41-48.
35. Shen H, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch K, Murphy DL, Hall FS, Uhl GR, Sora I. 2004. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacolgoy 29:1790-1799.
36. Vezina P, Blanc G, Glowinski J, Tassin JP. 1991. Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: A role for the cortical D-1 dopamine receptor. Eur J Neurosci 3:1001-1007.